Abstract
Objective
The purpose of this study was to evaluate the outcomes of prosthesis selection in hemodialysis patients undergoing valve replacement for aortic valve stenosis.
Methods
From July 2008 to December 2016, 76 patients on hemodialysis underwent aortic valve replacement for aortic valve stenosis. Of these patients, 30 patients were treated by a mechanical valve and 46 patients were treated by a bioprosthesis. Early outcomes and long-term outcomes were compared.
Results
The mean age of the patients treated by a mechanical valve was younger than the patients treated by a bioprosthesis (p < 0.001). There were no significant differences in in-hospital mortality (p = 0.52). For the long-term outcomes, complications associated with bleeding were higher in patients who received a mechanical valve (p = 0.032). However, no significant difference was observed in mortality (p = 0.65) and major adverse cardiovascular cerebrovascular event (MACCE: p = 0.59). The actuarial survival rate with a mechanical valve was 56.7% (95% CI 36.4–72.8%) at 3 years and 48.6% (95% CI 28.9–65.8%) at 5 years. The actuarial survival rate with a bioprosthesis was 61.2% (95% CI 44.0–74.5%) at 3 years and 39.5% (95% CI 20.9–57.8%) at 5 years. No patients from both groups needed redo surgery for valvular deterioration. Further, there was no significant difference in long-term mortality (p = 0.91) and MACCE (p = 0.63) in a propensity score-matched patient comparison.
Conclusions
Although bleeding complications were higher in patients who received a mechanical valve, there were no significant differences in early- and long-term mortality, and MACCE between patients treated by a mechanical valve and a bioprosthesis.
Similar content being viewed by others
References
Bianchi G, Solinas M, Bevilacqua S, Glauber M. Are bioprostheses associated with better outcome than mechanical valves in patients with chronic kidney disease requiring dialysis who undergo valve surgery? Interact Cardiovasc Thorac Surg. 2012;15:473–83.
van Geldorp MW, Eric Jamieson WR, Kappetein AP, Ye J, Fradet GJ, Eijkemans MJ, et al. Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg. 2009;137:881–886.e5.
Rahimtoola SH. Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol. 2003;41:893–904.
Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients in the United States with prosthetic heart valves: should ACC/AHA practice guidelines on valve selection be modified? Circulation. 2002;105:1336–41.
Masakane I, Nakai S, Ogata S, Kimata N, Hanafusa N, et al. Annual dialysis data report 2014, JSDT Renal Data Registry (JRDR). Renal Replace Ther. 2017;3:18.
Umana E, Ahmed W, Alpert MA. Valvular and perivalvular abnormalities in end-stage renal disease. Am J Med Sci. 2003;325:237–42.
Okada N, Tajima K, Takami Y, Kato W, Fujii K, Hibino M, et al. Valve selection for the aortic position in dialysis patients. Ann Thorac Surg. 2015;99:1524–31.
Phan K, Zhao DF, Zhou JJ, Karagaratnam A, Phan S, Yan TD. Bioprosthetic versus mechanical prostheses for valve replacement in end-stage renal disease patients: systematic review and meta-analysis. J Thorac Dis. 2016;8:769–77.
Masakane I, Hanafusa N, Kita T, Maeda K. Recent trends in home hemodialysis therapy in Japan. Contrib Nephrol. 2017;189:54–60.
Hori D, Yamaguchi A, Adachi H. Coronary artery bypass surgery in end-stage renal disease patients. Ann Vasc Dis. 2017;10:79–87.
Zhibing Q, Xin C, Ming X, Lele L, YingShuo J, LiMing W. Should bioprostheses be considered the valve of choice for dialysis-dependent patients? J Cardiothorac Surg. 2013;8:42.
Hirose H, Amano A, Takahashi A, Takanashi S. Coronary artery bypass grafting in patients on chronic hemodialysis: diabetic nephropathy versus nondiabetic nephropathy. Artif Organs. 2002;26:794–801.
Hosoda Y, Yamamoto T, Takazawa K, Yamasaki M, Yamamoto S, Hayashi I, et al. Coronary artery bypass grafting in patients on chronic hemodialysis: surgical outcome in diabetic nephropathy versus nondiabetic nephropathy patients. Ann Thorac Surg. 2001;71:543–8.
Vohra HA, Armstrong LA, Modi A, Barlow CW. Outcomes following cardiac surgery in patients with preoperative renal dialysis. Interact Cardiovasc Thorac Surg. 2014;18:103–11.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Hori, D., Kusadokoro, S., Kitada, Y. et al. Prosthesis selection for aortic valve replacement in patients on hemodialysis. Gen Thorac Cardiovasc Surg 68, 122–128 (2020). https://doi.org/10.1007/s11748-019-01172-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-019-01172-w